Mobile App Click here to download our Mobile App for iOS or Android
Not a member? Sign up for free!

Considerations For Patients Receiving Long-Acting Injectable Antipsychotics During COVID-19

Presentation | November 9, 2020

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

In this presentation, René Kahn, MD, PhD, PsychU Schizophrenia Section Advisor, discusses the impact of COVID-19 on long-acting injectable (LAI) antipsychotic administration, including safety and clinical considerations. Dr. Kahn will also discuss the personal protective equipment (PPE) recommendations from the Substance Abuse and Mental Health Services Administration (SAMHSA). René Kahn, MD, PhD, is the PsychU…

You must be logged in to read the full article: Join PsychU or Log In